SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tuck9/26/2017 9:26:49 AM
   of 3661
 
Axovant (AXON) off 74% after huge run up into late stage Alzheimer's Disease trial result, which failed on both endpoints. There is also a P2 in dementia with Lewy Bodies to read out by year end with the same drug if one is interested in a) buying today's weakness, or b) shorting the dead cat bounce. For the record, I was short a small position at just under $27 as noted in the binary events thread. Covered premarket for $6.30. Sorry, dementia patients and loved ones, this drug is not your salvation.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News